CRISPR Therapeutics (CRSP) Prices 6.428M Share Common Offering at $70/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Pre-Open Movers 06/30: (CARV) (BYFC) (BLNK) Higher; (OCX) (ZYNE) (GNW) Lower (more...)
June 30, 2020 9:27 AM EDTPre-Open Stock Movers
Carver Bancorp (NASDAQ: CARV) 174.6% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Broadway Financial (NASDAQ: BYFC) 88% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Blink Charging (NASDAQ: BLNK) 54% HIGHER; sees added momentum
Oncocyte Corporation (NYSE:... More
After-Hours Stock Movers 06/29: (XLNX) (MU) (LULU) Higher; (LQDA) (SYNC) (MLHR) Lower (more...)
June 29, 2020 6:05 PM EDTAfter-Hours Stock Movers
Qumu Corporation (Nasdaq: QUMU) 18.8% HIGHER; Synacor and Qumu announced that the companies have mutually agreed to terminate their proposed all-stock merger agreement, previously announced on February 11, 2020.
Liquidia Technologies, Inc. (NASDAQ: LQDA) 18.1% LOWER; announced today that it has commenced an underwritten public offering of its common stock
Synacor, Inc. (Nasdaq: SYNC) 8% LOWER; Synacor and Qumu Corporation (Nasdaq: QUMU) announced that the companies have... More
CRISPR Therapeutics (CRSP) Announces $325M Common Share Offering
June 29, 2020 4:02 PM EDTCRISPR Therapeutics (NASDAQ: CRSP) today announced that it is commencing an underwritten public offering of $325,000,000 of common shares. In addition, the underwriters will have a 30-day option to purchase up to an additional $48,750,000 of common shares at the public offering price less the... More
Piper Sandler Reiterates Bullish View on CRISPR Therapeutics (CRSP) Amid New Manufacturing Facility
June 29, 2020 8:59 AM EDTPiper Sandler analyst Edward Tenthoff reiterated an Overweight rating and $104.00 price target on CRISPR Therapeutics (NASDAQ: CRSP) citing a new manufacturing facility to produce cell therapies for clinical and commercial use, the hiring of up to 100 more full-time employees, Car-T advancing, and AACR II showing superior features of Allo Car-T Pipeline.
The... More
